Save time and get answers to complex questions with AI chat
When does guselkumab patent expire?Generic brand for latisse?Patent expiration date of guselkumab?Tenofovir generic patent?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for ozempic
Short answer: yes, Ozempic (semaglutide) often reduces appetite and can lessen cravings, especially for sweet or high-fat foods. But the effect varies by person and dose. Key points: - Mechanism: GLP-1 receptor activation slows stomach emptying and increases fullness, which tends to lower overall hunger and specific food cravings. - Dosing matters: At diabetes doses (e.g., 0.5–2 mg weekly), you may see modest appetite reduction and weight loss. At higher doses used for obesity (Wegovy), appetite suppression tends to be stronger and weight loss more pronounced. - Time course: Appetite and cravings may diminish over weeks of treatment, though some people still crave certain foods. Early GI side effects (nausea, vomiting, fullness) can also reduce appetite temporarily. - Individual variability: People respond differently. Some notice big changes in cravings; others feel only modest changes. Safety notes: - Ozempic is not approved for weight loss at the diabetes doses; Wegovy is the higher-dose option specifically approved for obesity. - Discuss with your clinician before starting, especially if you have a history of pancreatitis, gallbladder disease, medullary thyroid carcinoma, MEN syndromes, pregnancy, or other medical concerns. If you’d like, tell me your current dose, your goals (diabetes control, weight loss), and any cravings you’re experiencing, and I can tailor the guidance.
Other Questions About Ozempic :